DarioHealth Announces CFO Transition | DRIO Stock News

Author's Avatar
4 days ago
  • DarioHealth Corp. (DRIO, Financial) announces CFO transition, with Zvi Ben-David retiring and Chen Franco-Yehuda stepping in as CFO, Treasurer, and Secretary on May 15, 2025.
  • Franco-Yehuda brings extensive financial expertise from Pluri Inc., focusing on capital raising and M&A strategies.
  • Under Ben-David, DarioHealth evolved from a single-condition to a multi-condition digital health platform.

DarioHealth Corp. (DRIO), a prominent player in digital health solutions, announced a key leadership transition as CFO Zvi Ben-David is set to retire on May 15, 2025. The company has appointed Chen Franco-Yehuda as the new Chief Financial Officer, effective the same date, while Ben-David will stay until the end of June 2025 to facilitate a seamless transition before taking on an advisory role.

Franco-Yehuda joins DarioHealth with robust experience in the healthcare and life sciences sectors. Her previous role as CFO at Pluri Inc. saw her adeptly manage corporate finance, investor relations, and cross-border transactions, alongside securing significant capital through various fundraising efforts. Her strategic acumen earned her the Israeli CFO Excellence Award in January 2025.

Zvi Ben-David leaves an indelible mark on DarioHealth, having transformed it from a single-condition solution provider to a multi-condition digital health platform, expanding its services to include diabetes, hypertension, mental health, weight management, and musculoskeletal care.

Erez Raphael, CEO of DarioHealth, expressed gratitude for Ben-David’s dedication and contributions, noting that his financial leadership was pivotal in positioning Dario as a leader in digital health innovation. The company looks forward to leveraging Franco-Yehuda’s expertise to continue its growth trajectory.

For more information about DarioHealth Corp. and its array of digital health solutions, visit their official website.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.